EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Optical coherence tomography assessment of the impact of colchicine on non-culprit coronary plaque composition after myocardial infarction

Peter J Psaltis iD, Mau T Nguyen, Kuljit Singh, Ajay Sinhal, Dennis T L Wong, Richard Alcock, Sharmalar Rajendran, Rustem Dautov, Peter Barlis, Sanjay Patel, Thalia Salagaras, Jessica A Marathe und 11 weitere

Cardiovascular Research · 29.04.2025 · 121 (3) · 468-478

DOI: 10.1093/cvr/cvae191 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Cardiovascular Research, online erschienen am 27.08.2024. Verfasst von Peter J Psaltis und 22 weiteren Autor:innen. Beteiligte Einrichtung: Vascular Research Center, Lifelong Health Theme, South Australian Health and Medical Research Institute, North Terrace, Adelaide 5000, Australia. Hauptthemen laut MEDLINE: Colchicine, Tomography, Optical Coherence, Plaque, Atherosclerotic, Coronary Vessels. Die Arbeit wurde bisher 46-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: National Health and Medical Research Council of Australia, National Heart Foundation of Australia, Sylvia and Charles Viertel Charitable Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Low-dose colchicine reduces the risk of cardiovascular events after myocardial infarction (MI). The purpose of this study was to assess the effect of colchicine post-MI on coronary plaque morphology in non-culprit segments by optical coherence tomography (OCT). Methods and results COCOMO-ACS was a double-blind, placebo-controlled trial that randomized 64 patients (median age 61.5 years; 9.4% female) with acute non-ST-segment elevation MI to colchicine 0.5 mg daily or placebo for a median of 17.8 months in addition to guideline-recommended therapy. Participants underwent serial OCT imaging within a matched segment of non-culprit coronary artery that contained at least one lipid-rich plaque causing ≥20% stenosis. The primary outcome was the change in minimum fibrous cap thickness (FCT) in non-culprit segments from baseline to final visit. Of those randomized, 57 (29 placebo, 28 colchicine) had evaluable imaging at baseline and follow-up. Overall, colchicine had no effect on relative (placebo +48.0 ± 35.1% vs. colchicine +62.4 ± 38.1%, P = 0.18) or absolute changes in minimum FCT (+29.2 ± 20.9 µm vs. + 37.2 ± 21.3 µm, P = 0.18), or change in maximum lipid arc (−38.8 ± 32.2° vs. −54.8 ± 46.9°, P = 0.18) throughout the imaged non-culprit segment. However, in patients assigned colchicine, cap rupture was less frequent (placebo 27.6% vs. colchicine 3.6%, P = 0.03). In post hoc analysis of 43 participants who had been followed for at least 16 months, minimum FCT increased to a greater extent in the colchicine group (placebo +38.7 ± 25.4% vs. colchicine +64.7 ± 34.1%, P = 0.005).

Conclusion

In this study, OCT failed to detect an effect of colchicine on the minimum FCT or maximum lipid arc of plaques in non-culprit segments post-MI. The post hoc observation that minimum FCT increased to a greater extent with colchicine after more prolonged treatment suggests that longer-term studies may be required to detect the effect of anti-inflammatory therapies on plaque morphology by OCT. Clinical trial number Australian New Zealand Clinical Trials Registry Identifier, ACTRN12618000809235, registered on the 11 May 2018.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ColchicineTomography, Optical CoherencePlaque, AtheroscleroticCoronary VesselsNon-ST Elevated Myocardial InfarctionCoronary Artery DiseaseCoronary StenosisHumansFemaleMaleMiddle AgedDouble-Blind MethodAgedTreatment OutcomePredictive Value of TestsTime FactorsFibrosisRupture, Spontaneous

Stichwörter der Autor:innen

AtherosclerosisColchicineFibrous capInflammationMyocardial infarctionOptical coherence tomography

Substanzen

Colchicine

Autor:innen und Institutionen

  • Vascular Research Center, Lifelong Health Theme, South Australian Health and Medical Research Institute, North Terrace, Adelaide 5000, Australia.
  • Department of Cardiology, Central Adelaide Local Health Network, Port Road, Adelaide 5000, Australia.
  • Adelaide Medical School, University of Adelaide, North Terrace, Adelaide 5000, Australia.
  • Department of Cardiology, Gold Coast University Hospital, Gold Coast, Australia.
  • Department of Cardiology, Flinders Medical Center, Adelaide, Australia.
  • Victorian Heart Institute, Monash University, Clayton, Australia.

ORCID-Profile: Peter J Psaltis, Yu Kataoka

Förderung

  • National Health and Medical Research Council of Australia
  • National Heart Foundation of Australia
  • Sylvia and Charles Viertel Charitable Foundation
  • Future Leader Fellowships

Zitieren

APA

Psaltis, P. J., Nguyen, M. T., Singh, K., Sinhal, A., Wong, D. T. L., Alcock, R., Rajendran, S., Dautov, R., Barlis, P., Patel, S., Salagaras, T., Marathe, J. A., Bursill, C. A., Montarello, N. J., Nidorf, S. M., Thompson, P. L., Butters, J., Cuthbert, A. R., Yelland, L. N., …, & Nicholls, S. J. (2025). Optical coherence tomography assessment of the impact of colchicine on non-culprit coronary plaque composition after myocardial infarction. Cardiovascular Research, 121(3), 468-478. https://doi.org/10.1093/cvr/cvae191

Vancouver

Psaltis PJ, Nguyen MT, Singh K, Sinhal A, Wong DTL, Alcock R, et al. Optical coherence tomography assessment of the impact of colchicine on non-culprit coronary plaque composition after myocardial infarction. Cardiovascular Research. 2025;121(3):468-478. doi:10.1093/cvr/cvae191

BibTeX
@article{Psaltis2025,
  author = {Psaltis, Peter J and Nguyen, Mau T and Singh, Kuljit and Sinhal, Ajay and Wong, Dennis T L and Alcock, Richard and Rajendran, Sharmalar and Dautov, Rustem and Barlis, Peter and Patel, Sanjay and Salagaras, Thalia and Marathe, Jessica A and Bursill, Christina A and Montarello, Nicholas J and Nidorf, Stefan M and Thompson, Peter L and Butters, Julie and Cuthbert, Alana R and Yelland, Lisa N and Ottaway, Juanita L and Kataoka, Yu and Di Giovanni, Giuseppe and Nicholls, Stephen J},
  title = {Optical coherence tomography assessment of the impact of colchicine on non-culprit coronary plaque composition after myocardial infarction},
  journal = {Cardiovascular Research},
  year = {2025},
  volume = {121},
  number = {3},
  pages = {468--478},
  doi = {10.1093/cvr/cvae191}
}
Kostenlos starten →